111, Inc.
YI- Exchange
- Nasdaq
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001738906
In the last 90 days, 111, Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $498.4K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in 111, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2022
- Shares held
- 2.04M
- −1.26M (−38.2%) vs. Q3 2022
- Total value
- $6.14M
- −$2.70M (−30.5%) vs. Q3 2022
- New holders
- 3
- 5 more added
- Sold out
- 2
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $498.4K |
| Q1 2026 | 8 | $410.3K |
| Q4 2025 | 9 | $466.4K |
| Q3 2025 | 8 | $540.8K |
| Q2 2025 | 9 | $661.0K |
| Q1 2025 | 9 | $625.9K |
| Q4 2024 | 20 | $2.23M |
| Q3 2024 | 9 | $241.8K |
| Q2 2024 | 15 | $2.26M |
| Q1 2024 | 16 | $2.19M |
| Q4 2023 | 17 | $3.03M |
| Q3 2023 | 14 | $4.99M |
| Q2 2023 | 13 | $4.46M |
| Q1 2023 | 16 | $4.97M |
| Q4 2022 | 17 | $6.14M |
| Q3 2022 | 16 | $8.84M |
| Q2 2022 | 15 | $6.93M |
| Q1 2022 | 19 | $9.51M |
| Q4 2021 | 23 | $13.6M |
| Q3 2021 | 23 | $24.2M |
| Q2 2021 | 29 | $50.5M |
| Q1 2021 | 33 | $70.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding 111, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 777,212 | $2.35M | 0.00% | +41,321+5.6% | Added |
| Greenwoods Asset Management Hong Kong Ltd.SuperinvestorGreenwoods Asset Management | 348,863 | $1.05M | 0.06% | −487,577−58.3% | Reduced |
| Barclays PLC | 329,800 | $996.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 165,336 | $499.3K | 0.00% | −36,467−18.1% | Reduced |
| Renaissance Technologies LLC | 111,347 | $336.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 83,214 | $251.3K | 0.00% | +6,465+8.4% | Added |
| Invesco Ltd. | 59,924 | $181.0K | 0.00% | −7,085−10.6% | Reduced |
| Virtu Financial LLC | 33,398 | $101.0K | 0.01% | +364+1.1% | Added |
| Geode Capital Management, LLC | 33,100 | $99.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 26,000 | $78.5K | 0.00% | −82,398−76.0% | Reduced |
| Two Sigma Investments, LP | 20,900 | $63.1K | 0.00% | +20,900 | New |
| Susquehanna International Group, LLP | 15,306 | $46.2K | 0.00% | −15,978−51.1% | Reduced |
| Goldman Sachs Group Inc | 11,326 | $34.2K | 0.00% | +11,326 | New |
| Morgan Stanley | 10,491 | $31.7K | 0.00% | +282+2.8% | Added |
| UBS Group AG | 4,161 | $12.6K | 0.00% | +3,632+686.6% | Added |
| Tower Research Capital LLC (TRC) | 3,770 | $11.0K | 0.00% | −5,210−58.0% | Reduced |
| Wellspring Financial Advisors, LLC | 4,300 | – | – | +4,300 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −686,431−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |